Comparative study: Efficacy and tolerability of vildagliptin vs. pioglitazone as an add-on therapy to metformin in poorly controlled type 2 diabetes mellitus patients in Punjab

Journal Title: International Archives of Integrated Medicine - Year 2015, Vol 2, Issue 1

Abstract

Introduction: The incidence of diabetes in urban Punjab is on the rise and the number of diabetics is increasing year by year. Material and methods: This 24 week study was designed to compare vildagliptin versus pioglitazone as an add-on therapy in patients of type 2 diabetes mellitus inadequately controlled with metformin alone in Punjabi population. Sixty patients were randomized in two groups to receive either vildagliptin 100 mg (group 1) or pioglitazone 30 mg (group 2) in addition to metformin 1000 mg. The primary efficacy end point was change in FBG, PPG and HbA1c. Secondary end point included lipid profile, body weight and peripheral edema. Results: There was no significant difference between mean reduction in FBG, PPG and HbA1c in both groups. There was significant decrease in mean body weight in group 1 in contrast to significant increase in group 2. Both the treatment groups reported a significant decrease in TG, TC, LDL and increase in HDL. Conclusion: Vildagliptin displays robust efficacy with the added benefits of a much lower risk of peripheral edema, hypoglycemia and no weight gain, making it a promising alternative to pioglitazone as an add-on therapy to metformin in Punjabi population.

Authors and Affiliations

Amita Jindal, Rupinder Kaur, Mahesh Jindal

Keywords

Related Articles

Correlation of Thyroid Hormones with FSH, LH and Prolactin in Infertility in the Reproductive Age Group Women

Introduction: Measurement of prolactin and thyroid hormones, especially thyroid stimulating hormone (TSH), has been considered an important component of infertility work up in women. Thyroid dysfunctions interfere with n...

The study of diabetic complications in patients of newly diagnosed type 2 diabetes mellitus

Diabetes mellitus is the most prevalent metabolic non communicable disorder in the world. Diabetes mellitus type 2 is a long term metabolic disorder that is characterized by high blood sugar, insulin resistance, and rela...

Prevalence of Norovirus and epidemiology of acute gastroenteritis in children

Pediatric gastroenteritis is a major cause of childhood mortality and morbidity worldwide, especially in developing countries. Diarrhoea can be caused by a variety of different pathogens including bacteria, viruses and p...

Gallbladder wall thickening at ultrasonography - A review

The aim of the present review was providing help for the assessment of the correct interpretation of gallbladder wall thickening and differential diagnosis at ultrasonography. Gallbladder wall thickening is a frequent so...

Langerhans Cell Histiocytosis: Story of The Orphan Disease Beyond Dermatology

Langerhans cell histiocytosis (LCH), a rare proliferative disorder of cells that share phenotypic characteristics with dermal Langerhans cells, has long been considered an “orphan,” or neglected disease. Prior to its cur...

Download PDF file
  • EP ID EP506742
  • DOI -
  • Views 107
  • Downloads 0

How To Cite

Amita Jindal, Rupinder Kaur, Mahesh Jindal (2015). Comparative study: Efficacy and tolerability of vildagliptin vs. pioglitazone as an add-on therapy to metformin in poorly controlled type 2 diabetes mellitus patients in Punjab. International Archives of Integrated Medicine, 2(1), 83-94. https://europub.co.uk./articles/-A-506742